Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Operating Expenses | 300 | 290 | 330 | 350 | 290 |
| Operating Income | -300 | -290 | -330 | -350 | -290 |
| Other Income | -30 | 10 | 30 | 30 | 0 |
| Pre-tax Income | -330 | -280 | -300 | -320 | -290 |
| Net Income Continuous | -337 | -280 | -302 | -315 | -290 |
| Net Income | $-337 | $-280 | $-302 | $-315 | $-290 |
| EPS Basic Continuous Ops | -0.80 | N/A | -0.40 | N/A | -0.80 |
| EPS Diluted Continuous Ops | -0.80 | -0.20 | -0.40 | N/A | -0.80 |
| EBITDA(a) | $-280 | $-260 | $-310 | $-320 | $-286 |